- NCIt
- C203250
Loading cancer entity…
Loading cancer entity…
Clinical trials
65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05176665 | EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers | unknown | Phase 1 / Phase 2 | 152 | Shanghai EpimAb Biotherapeutics Co., Ltd.INDUSTRY | 2 | Aug 26, 2024 | clinicaltrials |
| NCT03622333 | Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines) | unknown | N/A | 60 | CHU de ReimsOTHER | 1 | Aug 20, 2018 | clinicaltrials |
| NCT00454376 | Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors | unknown | — | 408 | National Cancer Institute (NCI)NIH | 10 | Oct 29, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 26, 2024source: clinicaltrials